Navigation Links
Hypocalcemia in Medical News

Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel

... patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

Health Alliance Announces First Fracture Protection Program for Actonel(R) (risedronate sodium) Tablets

... patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis

... in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...
Hypocalcemia in Medical Technology

First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. All patients with Paget's disease should ...

Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. In the Pivotal Fracture Trial an increased ...

New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis

... in patients with hypocalcemia, known hypersensitivity to any component of this product, or inability to stand or sit upright for at least 30 minutes. hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Actonel therapy. Actonel is not recommended for ...

ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study

... cases, intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis

... osteoporosis. Reclast is contraindicated in patients with hypocalcemia (low blood calcium), hypersensitivity to zoledronic acid and in women who ... already being treated with Zometa should not be treated with Reclast. hypocalcemia may occur with Reclast therapy. All patients with Paget's disease should ...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

... intravenous replacement was required. Patients receiving ERBITUX therapy should be periodically monitored for hypomagnesemia, and accompanying hypocalcemia and hypokalemia during, and up to 8 weeks following the completion of, ERBITUX therapy. The most serious adverse reactions associated with ERBITUX ...

Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

... Grade 4 lymphopenia, neutropenia and thrombocytopenia were observed in 1, 2 and 2 patients, respectively. Grade 1-3 anemia, nausea/vomiting and hypocalcemia were observed in 18, 1, and 3 patients, respectively. “Myelosuppression, particularly neutropenia, is a substantial clinical problem in ...

More>>

Hypocalcemia in Medical Products

MM-PTH RIA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

C-PTH RIA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

I-PTH IRMA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.

I-PTH ELISA Test

Description:... hormone (PTH) is synthesized by the parathyroid glands [1,2] and secreted in response to decreased extracellular calcium concentrations. PTH prevents hypocalcemia by enhancing bone resorption and decreasing calcium excretion by the kidney. Following release into the circulation, intact PTH is rapidly degraded ...
Company:Diagnostic Systems Laboratories, Inc.
Hypocalcemia in Medical Dictionary

Hypocalcemia

... hypocalcemia is a condition in which there is too little calcium in the blood . A common form of hypocalcemia in babies is called neonatal hypocalcemia . This condition may occur at different times ...

Hyperventilation

... - Spasm s of the hands or feet that may be seen in association with hypocalcemia or hyperventilation . [ Med Help International ] [ Search ] [ Ask the ... medications used to treat diabetes . Hyperventilation syndrome hypocalcemia Hypoglycemia , insulin -reaction * - Hypothermia Hypothyroidism ...

Calcium

... disorders (that is, disease s of the para thyroid gland or kidney s). Calcium deficiency : A low level of calcium in the blood ( hypocalcemia ) which can make the nervous system highly irritable causing tetany ( spasm s of the hands and feet, muscle cramps , abdominal cramps , and ...

Calcium phosphate

... and coma , while prolonged and moderate hypercalcemia results in the deposit of calcium phosphate crystals in the kidney s and eye . hypocalcemia occurs when serum free calcium ions fall below 4. Bone: Bone is the substance that forms the skeleton of the body. It is composed chiefly ...

Dextrose

... ). ARTICLE TOOLS Print ... hypoglycemia - low blood sugar ; usually treated with IV fluids containing dextrose (another form of sugar ). hypocalcemia - low calcium levels in the blood ; usually treated with calcium in IV fluids. The body makes glucose from protein s, fats and, in ...

Hypercalcemia

... disorder of iron overload ( hemochromatosis ) or excessive blood levels of calcium ( hypercalcemia ). When blood calcium levels fall ( hypocalcemia ), calcium is released from bones to restore proper blood levels. When blood calcium levels rise ( hypercalcemia ), the excess calcium may ...

Hypoglycemia

... to store sugar instead of burning the sugar for energy. This causes too little sugar in the blood , a condition called hypoglycemia . hypocalcemia Hypoglycemia , insulin -reaction * - Hypothermia Hypothyroidism - diagnosis and treatment - diagnosis and treatment , brief ...

Low blood sugar

... large internal organ s, and defects of the abdominal wall near the navel. Hypo-: Prefix meaning "low, under, beneath, down, below normal" as in hypocalcemia (low calcium in the blood ), hypoglycemia ( low blood sugar ) and hyposensitivity. The opposite of hypo- is hyper-. See also: Sub-. ...

Pedal

... CARPO PEDAL SPASM - Spasm s of the hands or feet that may be seen in association with hypocalcemia or hyperventilation . [ Med Help International ] [ Search ] [ Ask the Doctor Forums ] ... Alternate Names : Carpo pedal Spasm , Foot Spasm s, ...

Tetany

... of an abnormality in calcium level, which can be linked to the following: ... Calcium deficiency : A low level of calcium in the blood ( hypocalcemia ) which can make the nervous system highly irritable causing tetany ( spasm s of the hands and feet, muscle cramps , abdominal cramps , and ...

More>>

Hypocalcemia in Biological Technology

FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML

... The frequency of Grade 3/4 hypophosphatemia and hypocalcemia was 8% and 2%, respectively, in the SPRYCEL 100 ... in the Gleevec group. The frequency of Grade 3/4 hypocalcemia was 4% in the SPRYCEL group and 0% in the Gleevec ... or interruption. Patients developing Grade 3/4 hypocalcemia during the course of SPRYCEL therapy often had ...

Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

... certain oncology indications. Reclast is contraindicated in patients with hypocalcemia (low blood calcium) and those who are allergic to zoledronic acid. Reclast ... by the prescriber prior to initiation of bisphosphonate treatment. hypocalcemia may occur with Reclast therapy. In the Pivotal Fracture Trial an increased ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... electrolyte abnormalities occurred days to months after initiation of ERBITUX therapy - Monitor patients periodically for hypomagnesemia, hypocalcemia and hypokalemia, during, and for at least 8 weeks following the completion of, ERBITUX therapy - Replete electrolytes as necessary Late ...

Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.

... and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (CRF) and by endocrinologists for the management of hypocalcemia in patients with post-surgical hypoparathyroidism, idiopathic hypoparathyroidism and pseudohypoparathyroidism. About ROCALTROL(R) (calcitriol) ...
Other Contents
(Date:7/9/2014)... and subjective, the human brain turns them into ... different senses, situations and even people, reports a ... , "We discovered that fine-grained patterns of neural ... the brain associated with emotional processing, act as ... feeling," says Anderson, associate professor of human development ...
(Date:7/9/2014)... declines and extinctions around the world have been ... but new research from the National Institute for ... pathogen, ranavirus, may also contribute. , In ... ranavirus, which causes severe hemorrhage of internal organs ... of wood frogs if they are exposed to ...
(Date:7/9/2014)... one of the most important organs in the human ... our food properly this is its synthesis function ... organism this is its detoxification function. Lack of ... all damage the liver. The resulting diseased cells can ... life-threatening liver failure. According to the German Liver Foundation, ...
(Date:7/9/2014)... , , , , , ... , , , , ... was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , ... , , , , , ...
(Date:7/8/2014)... enjoy similar longevity and cardiovascular health as other healthy ... the American Journal of Transplantation . The findings ... and the transplant professionals caring for them. , Over ... aged 55 years and older has become more common. ... heart disease, the removal of a kidney could make ...
Breaking Medicine News(10 mins):Health News:Study cracks how the brain processes emotions 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:Study finds kidney donation safe for healthy older adults 2
(Date:7/9/2014)... developed by researchers at the NIH,s National ... its collaborators to treat sickle cell disease ... business. The drug candidate, Aes-103, is the ... molecular mechanism of sickle cell disease. Baxter ... required for regulatory approval and commercialization. , ...
(Date:7/9/2014)... receptor antagonists can alleviate the symptoms of ... cognitive dysfunction and effectively scavenge amyloid beta ... (Aβ) vaccines reduced and eliminated Aβ deposition ... model, and significantly improved behavioral and cognitive ... First Affiliated Hospital of China Medical University, ...
(Date:7/9/2014)... inhabitants of the sea: tiny haptophytes of the type ... eye, when they are in bloom in spring, they ... on satellite images. "Together with other phytoplankton, Emiliania ... global photosynthesis output," states Prof. Dr. Georg Pohnert of ... the greenhouse gas carbon dioxide CO2 is ...
Breaking Biology News(10 mins):First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4Short circuit in the food web 2
Other TagsOther Tags